Literature DB >> 11442166

Cryptogenic epilepsy: an infectious etiology?

E W Stommel1, R Seguin, V M Thadani, J D Schwartzman, K Gilbert, K A Ryan, T D Tosteson, L H Kasper.   

Abstract

PURPOSE: Cryptogenic epilepsy, the group of epilepsy syndromes for which an etiology is unknown, comprises approximately 20% of all epilepsy syndromes. We selected patients in this subgroup of epilepsy and tested them for evidence of Toxoplasma gondii IgG antibodies by the enzyme-linked immunosorbent assay. T. gondii is found in up to 20% of the U.S. population forming dormant brain cysts in the latent bradyzoite form. We investigated the hypothesis that dormant T. gondii infection might be associated with cryptogenic epilepsy.
METHODS: We selected patients with cryptogenic epilepsies and tested them for evidence of T. gondii IgG antibodies by the enzyme-linked immunosorbent assay. A control group was also tested for comparison.
RESULTS: We have found a statistically-significant elevation of T. gondii antibodies among cryptogenic epilepsy patients as compared to controls [59% increase in optical density (OD), p = 0.013]. This association persisted after adjustment for subjects' gender and age in a multiple logistic regression model; however, it was no longer as statistically significant.
CONCLUSIONS: Our results suggest that chronic T. gondii infection with brain cysts may be a cause of cryptogenic epilepsy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11442166     DOI: 10.1046/j.1528-1157.2001.25500.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  30 in total

1.  Molecular cloning and characterization of an SRCAP chromatin remodeling homologue in Toxoplasma gondii.

Authors:  William J Sullivan; M Alexandra Monroy; Wolfgang Bohne; Karuna C Nallani; John Chrivia; Peter Yaciuk; Charles K Smith; Sherry F Queener
Journal:  Parasitol Res       Date:  2003-01-28       Impact factor: 2.289

Review 2.  Interferon-gamma- and perforin-mediated immune responses for resistance against Toxoplasma gondii in the brain.

Authors:  Yasuhiro Suzuki; Qila Sa; Marie Gehman; Eri Ochiai
Journal:  Expert Rev Mol Med       Date:  2011-10-04       Impact factor: 5.600

3.  Recurrent headaches may be caused by cerebral toxoplasmosis.

Authors:  Joseph Prandota; Anna Gryglas; Aleksander Fuglewicz; Agata Zesławska-Faleńczyk; Barbara Ujma-Czapska; Leszek Szenborn; Janusz Mierzwa
Journal:  World J Clin Pediatr       Date:  2014-08-08

4.  MYST family histone acetyltransferases in the protozoan parasite Toxoplasma gondii.

Authors:  Aaron T Smith; Samantha D Tucker-Samaras; Alan H Fairlamb; William J Sullivan
Journal:  Eukaryot Cell       Date:  2005-12

5.  Host Cell Preference of Toxoplasma gondii Cysts in Murine Brain: A Confocal Study.

Authors:  T C Melzer; H J Cranston; L M Weiss; S K Halonen
Journal:  J Neuroparasitology       Date:  2010

6.  Anti-Toxoplasma gondii antibodies in patients with schizophrenia--preliminary findings in a Turkish sample.

Authors:  Zafer Cetinkaya; Suleyman Yazar; Omer Gecici; Mustafa N Namli
Journal:  Schizophr Bull       Date:  2007-04-02       Impact factor: 9.306

7.  Transcriptome analysis of mouse brain infected with Toxoplasma gondii.

Authors:  Sachi Tanaka; Maki Nishimura; Fumiaki Ihara; Junya Yamagishi; Yutaka Suzuki; Yoshifumi Nishikawa
Journal:  Infect Immun       Date:  2013-07-15       Impact factor: 3.441

8.  Toxoplasma IgG and IgA, but not IgM, antibody titers increase in sera of immunocompetent mice in association with proliferation of tachyzoites in the brain during the chronic stage of infection.

Authors:  Jatinder Singh; Carmine Graniello; Yanyan Ni; Laura Payne; Qila Sa; James Hester; Brent J Shelton; Yasuhiro Suzuki
Journal:  Microbes Infect       Date:  2010-08-11       Impact factor: 2.700

9.  Recurrent seizures during acute acquired toxoplasmosis in an immunocompetent traveller returning from Africa.

Authors:  Anna Beltrame; Sergio Venturini; Giovanni Crichiutti; Valeria Meroni; Dora Buonfrate; Matteo Bassetti
Journal:  Infection       Date:  2015-07-14       Impact factor: 3.553

Review 10.  Toxoplasma gondii: host-parasite interaction and behavior manipulation.

Authors:  Rodrigo Costa da Silva; Helio Langoni
Journal:  Parasitol Res       Date:  2009-06-23       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.